In collaboration with Payame Noor University and Iranian Society of Physiology and Pharmacology

Document Type : Article

Authors

1 Assistant Professor, Department of Biology, Marand Branch, Islamic Azad University, Marand, Iran ‎

2 Ph. D., Drug Applied Research Center, Tabriz ‎University of Medical Sciences, Tabriz 51664, Iran

Abstract

Alzheimer's disease is a common form of progressive dementia and usually occurs between the sixth and ninth decades of life, given that there is a direct relationship between steroid hormones and neurodegenerative diseases, so the present study was designed to explore effect of testosterone in memory impairment induced by intra-cerebroventricular (icv) injection of streptozptocin (STZ) as a model of sporadic Alzheimer disease (AD). Study was carried out on male Wistar rats. Adult male Wistar rats were intracerebroventricularly (icv) infused with STZ (3mg/kg/icv) on d 1 and d 3, and a passive avoidance task was assessed 2 weeks after the first injection of STZ. Castration surgery was performed in another group of rats, and the passive avoidance task was assessed 4 weeks after the operation. Testosterone (1 mg/kg.d, SC), the androgen receptor antagonist flutamide (10 mg/kg.d, ip), the estrogen receptor antagonist tamoxifen (1 mg/kg.d, ip) or the aromatase inhibitor letrozole (4 mg/kg.d, ip) were administered for 6 d after the first injection of STZ.  STZ administration and castration markedly decreased both STL1 (the short memory) and STL2 (the long memory) in passive avoidance tests. Testosterone replacement almost restored the STL1 and STL2 in castrated rats, and significantly prolonged the STL1 and STL2 in STZ-treated rats. Administration of flutamide, letrozole or tamoxifen significantly impaired the memory in intact rats, and significantly attenuated the testosterone replacement in improving STZ- and castration-induced memory impairment. Testosterone administration ameliorates STZ- and castration-induced memory impairment in male Wistar rats.

Keywords

Agonist and antagonist activities of hydroxyl flutamideand Casodex relate to androgen receptor stabilization. Urology; 48: 157-63.
Cherrier, M.M.; et al. (2005). The role of aromatization in testosterone supplementation: effects on cognition in older men. Neurology; 64: 290-6.
Compton, J.; et al. (2002). Cognition and Alzheimer’s disease. Best Pract Res Clin Obstet Gynaecol; 16: 357-70.
Gibbs, R.B. (2005). Testosterone and estradiol produce different effects on cognitive performance in male rats. Horm Behav; 48: 268-77.
Gillett, M.J.; Martins, R.N. (2003). Relationship between testosterone, sex hormone binding globulin and plasma amyloid beta peptide 40 in older men with subjective memory loss or dementia. J Alzheimers Dis; 5: 267-9.
Goodenough, S.; Engert, S. (2000). Testosterone stimulates rapid secretory amyloid precursor protein release from rat hypothalamic cells via the activation of the mitogen activated protein kinase pathway. Neurosci Lett; 296: 49-52.
Gouras, G.K.; et al. (2000). Testosterone reduces neuronal secretion of Alzheimer’s beta-amyloid peptides. Proc Natl Acad Sci U S A; 97: 1202-5.
Greene, J.D.; Baddeley, A. (1996). Analysis of the episodic memory deficit in early Alzheimer’s disease: evidence from the doors and people test. Neuropsychologia; 34:537-51.
Haass, C.; Selkoe, D.J. (2007). Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer’s amyloid beta-peptide. Nat Rev Mol Cell Biol; 8: 101-12.
Hammond, J.; et al. (2000). Intra hippocampal injection of testosterone impaired acquisition, consolidation and retrieval of inhibitory avoidance learning and memory in adult male rats. Behav Brain Res; 188(1): 71-7.
Jaffe, A.B.; Gandy, S.E. (1994). Estrogen regulates metabolism of Alzheimer amyloid beta precursor protein. J Biol Chem; 269: 13065-8.
Jakab, R.L.; Horvath, TL. (1993). Aromataseimmunoreactivity in the rat braingonadectomy-sensitive hypothalamicneurons and an unresponsive ‘limbic ring’ of the lateral septumbednucleus- amygdala complex. J Steroid Biochem Mol Biol; 44: 481-98.
Kemppainen, J.A.; Wilson, E.M. (1996).  
Kirk, A.; Kertesz, A. (1991). On drawing impairment in Alzheimer’s disease. Archives of Neurology; 48:73-7.
Leranth, C.; Hajszan, T. (2004). Androgens increase spine synapse density in the CA1 hippocampal subfield of ovariectomized female rats. J Neurosci; 24: 495-9.
Levin-Allerhand, J.A.; Lominska, C.E. (2002). 17alpha-Estradiol and 17 beta- estradiol treatments are effective in lowering cerebral amyloid-beta levels in Abeta PPSWE transgenic mice. J Alzheimers Dis 2002; 4: 449-57.
Long, J.B. (1983). Effect of castration and adernalectomy on in vitro rates of tryptophan hydroxylation and levels of serotonin in microdissected brain nuclei of adult male rats. Brain Ress; 277: 289-297.
Mohajjel Nayebi, A.; Pourrabie, S.R.; Hosseni, S.E. (2014). Testosterone ameliorates streptozotocin-induced memory impairment in male rats. Acta pharmacological cinica; 35: 752-757.
Mooradian, A.D.; Morley, J.E. (1987). Biological actions of androgens. Endocr Rev 1987; 8: 1-28.
Naftolin, F.; Ryan, K.J. (1972). Aromatization of androstenedione by the anterior hypothalamus of adult male and female rats. Endocrinology; 90: 295-8.
Packard, M.G.; Kohlimaire, J.R. (1996).  Post training intrahippocampal estradiol injections enhance spatial memory in male rats: interaction with cholinergic system. Behav Neurosci; 110: 626-32.
Palmer, A. M., Stratmann, G. C.; Procter, A. W.; Bowen, D. M. (1988). Possible neurotransmitter basis of behavioral changes in Alzheimer's disease. Annals of Neurology: Official Journal of the American Neurological Association and the Child Neurology Society, 23(6), 616-620.
Papasozomenos, S.C. (1997). The heat shock-induce hyperphosphorylation of tau is estrogen-independent and prevented by androgens: implications for Alzheimer’s disease. Proc Natl Acad Sci U S A; 94: 6612-7.
Papasozomenos, S.Ch.; Shanavas, A.; (2002). estosterone prevents the heat shock-induced overactivation of glycogen synthase kinase-3 beta but not of cyclin-dependent kinase 5 and c-Jun NH2-terminal kinase and concomitantly abolishes hyperphosphorylation of tau: implications for Alzheimer’s disease. Proc Natl Acad Sci U S A; 99: 1140-5.
Pappas, B.A.; Bayley, P.J. (2000). Choline acetyltransferase activity nd cognitive domain scores of Alzheimer’s patients. Neurobiol Aging; 21: 1-7.
Paxinos, G.; Watson, C. (1986). The rat brain in stereotaxic coordinates. 2nd ed. San Diego: Academic Press.
Pike, C.J.; Nguyen, T.V. (2008).  Androgen cell signaling pathways involved in neuroprotective actions. Horm Behav; 53: 693-705.
Pike, C.J.; Rosario, E.R. (2006).  Androgens, aging, and Alzheimer’s disease. Endocrine; 29: 233-41.
Pillon, B.; Deweer, B. (1993). Explicit memory in Alzheimer’s, Huntington’s, and Parkinson’s diseases. Arch Neurol; 50: 374-9.
Price, B.H.; Gurvit, H. (1993). Neuropsychological patterns and language deficits in 20 consecutive cases of autopsy-confirmed Alzheimer’s disease. Arch Neurol; 50: 931-7
Rosario, E.R.; Chang, L. (2004). Age-related testosterone depletion and the development of Alzheimer disease. JAMA; 292: 1431-2.
Shingo, A.S.; Kanabayashi, T. (2012). Cognitive decline in STZ-3V rats is largely due to dysfunctional insulin signalling through the dentate gyrus. Behav Brain Res; 229: 378-83.
Simpson, E.R.; Davis, S.R. (2001). Minireview: aromatase and the regulation of estrogen biosynthesis-some new perspectives. Endocrinology; 142: 4589-94.
Singh, S.M.; Gauthier, S. (2000). Androgen receptor antagonists (antiandrogens): structure-activity relationships. Curr Med Chem; 7: 211-47.
Spritzer, M.D.; Daviau, E.D. (2011).  Effects of testosterone on spatial learning and memory in adult male rats. Horm Behav; 59: 484-96.
Weill-Engerer, S.; David, J.P. (2002). Neurosteroid quantification in human brain regions: comparison between Alzheimer’s and no demented patients. J Clin Endocrinol Metab; 87: 5138-43.